Loading company…
Folsom biotech supplying cellular products such as Leukopaks and blood products for cell and gene therapy research.
StemExpress, LLC supplies healthy and disease-state Leukopaks, mobilized Leukopaks, bone marrow, cord blood and isolated cells to research institutions, biotechnology firms and pharmaceutical companies. Products are offered under Good Manufacturing Practice regulations for clinical trial use. Founded in 2010 in Folsom, US, the company is led by CEO Cate Dyer and received an undisclosed seed investment from IndieBio and SOSV on June 22, 2018.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in